EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A causal association between Epstein-Barr virus infection and lung cancer: A two-sample Mendelian Randomization study

Jia Wang, Kai Wang iD, Zhishang Wang

Cancer Biomarkers · 2026-06 · 43

DOI: 10.1177/18758592261463308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, online erschienen am 04.07.2026. Verfasst von Jia Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Affiliated Hospital of Yan 'an University, Yan 'an, Shaanxi, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Epstein-Barr Virus Infections, Herpesvirus 4, Human. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The association between Epstein-Barr virus (EBV) and lung cancer risk remains controversial. Here, we used a two-sample Mendelian randomization (MR) analysis to test the causal relationship between EBV and lung cancer.

Methods

Data regarding lung cancer (outcomes) were collected from the Finnish database; the Genome-Wide Association Study (GWAS) summary-level dataset for EBV was obtained from the Open Forum Infect Dis. The inverse-variance weighted (IVW) method was used as a primary analytical approach; weighted median, MR-Egger, and weighted mode methods were used to ensure the robustness of the data. The MR-Egger regression assessed horizontal pleiotropy, and the MR pleiotropy residual sum and outlier (MR-PRESSO) method identified potential outliers. Cochran’s Q test evaluated heterogeneity among instrumental variables (IVs).

Results

IVW analysis indicated several significant causal effects. Genetically elevated levels of EBV ZEBRA and EBNA-1 antibodies increased the risk of SQC (OR=1.26 and OR=1.33, respectively). Increased EBNA-1 antibodies also raised the risk of overall lung cancer and small cell lung cancer. Conversely, higher VCA p18 antibody levels were associated with a decreased risk of lung adenocarcinoma (OR=0.70). Sensitivity analyses suggested these findings were robust, with no significant evidence of horizontal pleiotropy or heterogeneity.

Conclusion

Our data suggests a causal effect between EBV and the progression of lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsEpstein-Barr Virus InfectionsHerpesvirus 4, HumanHumansMendelian Randomization AnalysisGenome-Wide Association StudyPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

EBVMendelian Randomizationcausalitylung cancersingle nucleotide polymorphism

Autor:innen und Institutionen

  • Department of Oncology, Affiliated Hospital of Yan 'an University, Yan 'an, Shaanxi, China.
  • Department of Thoracic Surgery, Affiliated Hospital of Yan 'an University, Yan 'an, Shaanxi, China.

ORCID-Profile: Kai Wang

Zitieren

APA

Wang, J., Wang, K., & Wang, Z. (2026). A causal association between Epstein-Barr virus infection and lung cancer: A two-sample Mendelian Randomization study. Cancer Biomarkers, 43. https://doi.org/10.1177/18758592261463308

Vancouver

Wang J, Wang K, Wang Z. A causal association between Epstein-Barr virus infection and lung cancer: A two-sample Mendelian Randomization study. Cancer Biomarkers. 2026;43. doi:10.1177/18758592261463308

BibTeX
@article{Wang2026,
  author = {Wang, Jia and Wang, Kai and Wang, Zhishang},
  title = {A causal association between Epstein-Barr virus infection and lung cancer: A two-sample Mendelian Randomization study},
  journal = {Cancer Biomarkers},
  year = {2026},
  volume = {43},
  doi = {10.1177/18758592261463308}
}
Kostenlos starten →